{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:54:05Z","timestamp":1765828445351,"version":"3.41.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.pharma.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:47:28Z","timestamp":1738082848000},"page":"675-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Green approach for simultaneous determination of long-acting \u03b2-agonists, their organic counterparts and corticosteroids by HPLC coupled with PDA detector"],"prefix":"10.1016","volume":"83","author":[{"given":"Sweta","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pharma.2025.01.009_bib0155","doi-asserted-by":"crossref","first-page":"100229","DOI":"10.1016\/j.opresp.2022.100229","article-title":"Impact of air pollution on asthma: a scoping review","volume":"5","author":"Bronte-Moreno","year":"2023","journal-title":"Open Respir Arch"},{"issue":"12","key":"10.1016\/j.pharma.2025.01.009_bib0160","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1080\/02770903.2023.2228911","article-title":"An update on asthma diagnosis","volume":"60","author":"Armeftis","year":"2023","journal-title":"J Asthma"},{"issue":"6","key":"10.1016\/j.pharma.2025.01.009_bib0165","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","article-title":"Pathogenesis of asthma","volume":"38","author":"Holgate","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.pharma.2025.01.009_bib0170","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1378\/chest.113.4.1095","article-title":"Long-acting inhaled \u03b22-agonists in asthma therapy","volume":"113","author":"Moore","year":"1998","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.pharma.2025.01.009_bib0175","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1517\/14656566.2015.1070826","article-title":"Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid\/long-acting \u03b22-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment","volume":"16","author":"Pelaia","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.pharma.2025.01.009_bib0180","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jpba.2005.09.028","article-title":"Validation of a reverse-phase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate)","volume":"40","author":"Murnane","year":"2006","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"10.1016\/j.pharma.2025.01.009_bib0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1556\/AChrom.27.2015.2.8","article-title":"HPLC method for simultaneous determination of salmeterol xinafoate and fluticasone propionate for the quality control of dry powder inhalation products","volume":"27","author":"Paczkowska","year":"2015","journal-title":"Acta Chromatogr"},{"issue":"4","key":"10.1016\/j.pharma.2025.01.009_bib0190","first-page":"1","article-title":"A validated stability indicating RP-HPLC method for simultaneous estimation of salmeterol xinafoate and fluticasone propionate in bulk and pharmaceutical dosage form","volume":"8","author":"Khalil Ahmed Bakhshi","year":"2018","journal-title":"Curr Pharm Res"},{"issue":"3","key":"10.1016\/j.pharma.2025.01.009_bib0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.arabjc.2015.05.005","article-title":"Forced degradation of mometasone furoate and development of two RP-HPLC methods for its determination with formoterol fumarate or salicylic acid","volume":"9","author":"El-Bagary","year":"2016","journal-title":"Arab J Chem"},{"issue":"2","key":"10.1016\/j.pharma.2025.01.009_bib0200","first-page":"219","article-title":"Stability indicating HPLC method for simultaneous estimation of mometasone furoate and formoterol fumarate in combined dosage form","volume":"5","author":"Gujarati","year":"2014","journal-title":"Pharmacophore"},{"issue":"5","key":"10.1016\/j.pharma.2025.01.009_bib0205","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0731-7085(03)00425-4","article-title":"Validation of a RP-HPLC method for the assay of formoterol and its related substances in formoterol fumarate dihydrate drug substance","volume":"33","author":"Akapo","year":"2003","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"10.1016\/j.pharma.2025.01.009_bib0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3797\/scipharm.1204-06","article-title":"A rapid, stability-indicating RP-HPLC method for the simultaneous determination of formoterol fumarate, tiotropium bromide, and ciclesonide in a pulmonary drug product","volume":"80","author":"Trivedi","year":"2012","journal-title":"Sci Pharm"},{"issue":"4","key":"10.1016\/j.pharma.2025.01.009_bib0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3797\/scipharm.1404-11","article-title":"Validation of an HPLC analytical method for the quantitative\/qualitative determination of fluticasone propionate in inhalation particles on several matrices","volume":"82","author":"Couto","year":"2014","journal-title":"Sci Pharm"},{"issue":"6","key":"10.1016\/j.pharma.2025.01.009_bib0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1255\/ejms.1044","article-title":"A high-throughput liquid chromatography tandem mass spectrometry method for the comparative determination of fluticasone propionate by reversed-phase liquid chromatography and capillary electrophoresis methods in pharmaceutical nasal sprays","volume":"15","author":"Da Silva Sangoi","year":"2009","journal-title":"Eur J Mass Spectrom"},{"issue":"14","key":"10.1016\/j.pharma.2025.01.009_bib0225","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1080\/10826070802225395","article-title":"Validation of a stability indicating reversed-phase LC method for the determination of fluticasone propionate in pharmaceutical formulations","volume":"31","author":"Sangoi","year":"2008","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"2","key":"10.1016\/j.pharma.2025.01.009_bib0230","first-page":"137","article-title":"Stability indicating RP-HPLC method development and validation for the simultaneous determination of vilanterol trifinatate and umeclidinium bromide in bulk and pharmaceutical dosage forms","volume":"9","author":"Priyadarshini","year":"2021","journal-title":"World J Pharm Med Res"},{"issue":"10","key":"10.1016\/j.pharma.2025.01.009_bib0235","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/chir.23105","article-title":"Enantiomeric separation of vilanterol trifenatate by chiral liquid chromatography","volume":"31","author":"Guo","year":"2019","journal-title":"Chirality"},{"issue":"8","key":"10.1016\/j.pharma.2025.01.009_bib0240","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/chromsci\/bmad075","article-title":"A novel RP-HPLC Method for simultaneous estimation of vilanterol trifenatate, umeclidinium bromide and fluticasone furoate in inhalation dry powder formulation","volume":"62","author":"Yadav","year":"2024","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.pharma.2025.01.009_bib0245","doi-asserted-by":"crossref","first-page":"121457","DOI":"10.1016\/j.ijpharm.2022.121457","article-title":"The future of dry powder inhaled therapy: promising or discouraging for systemic disorders?","volume":"614","author":"Ye","year":"2022","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.pharma.2025.01.009_bib0250","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.apt.2016.10.022","article-title":"Optimized particle engineering of fluticasone propionate and salmeterol xinafoate by spray drying technique for dry powder inhalation","volume":"28","author":"Khandouzi","year":"2017","journal-title":"Adv Powder Technol"},{"key":"10.1016\/j.pharma.2025.01.009_bib0255","series-title":"International conference on harmonization","article-title":"Validation of analytical procedures: text and methodology Q2 (R1)","author":"Guideline","year":"2005"},{"key":"10.1016\/j.pharma.2025.01.009_bib0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.pharma.2025.01.009_bib0265","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.greeac.2024.100107","article-title":"Greenness appraisal and development of validated spectrophotometric methods for assay of amprolium: comparative study using Analytical Eco-Scale, GAPI, and AGREEmetric approaches","volume":"9","author":"El-Sayed","year":"2024","journal-title":"Green Anal Chem"},{"issue":"19","key":"10.1016\/j.pharma.2025.01.009_bib0270","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem"},{"key":"10.1016\/j.pharma.2025.01.009_bib0275","doi-asserted-by":"crossref","first-page":"100112","DOI":"10.1016\/j.greeac.2024.100112","article-title":"A comparative greenness assessment of chromatographic methods for cilnidipine analysis and its combination","volume":"9","author":"Suthar","year":"2024","journal-title":"Green Anal Chem"},{"key":"10.1016\/j.pharma.2025.01.009_bib0280","doi-asserted-by":"crossref","first-page":"116223","DOI":"10.1016\/j.trac.2021.116223","article-title":"White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality","volume":"138","author":"Nowak","year":"2021","journal-title":"Trends Anal Chem"},{"issue":"3","key":"10.1016\/j.pharma.2025.01.009_bib0285","doi-asserted-by":"crossref","first-page":"106685","DOI":"10.1016\/j.microc.2021.106685","article-title":"Environmental impact of greenness assessment tools in liquid chromatography\u00a0\u2013\u00a0a review","volume":"170","author":"Kannaiah","year":"2021","journal-title":"Microchem J"},{"issue":"14","key":"10.1016\/j.pharma.2025.01.009_bib0290","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u00a0\u2013\u00a0Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.pharma.2025.01.009_bib0295","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1016\/j.sampre.2022.100025","article-title":"A tutorial on AGREEprep an analytical greenness metric for sample preparation","volume":"3","author":"Pena-Pereira","year":"2022","journal-title":"Adv Sample Prep"},{"key":"10.1016\/j.pharma.2025.01.009_bib0300","doi-asserted-by":"crossref","first-page":"100149","DOI":"10.1016\/j.greeac.2024.100149","article-title":"Application of seven tools for evaluation of greenness of chromatographic methods for Remdesivir analysis","volume":"11","author":"Bhalodia","year":"2024","journal-title":"Green Anal Chem"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T12:59:03Z","timestamp":1749905943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0003450925000094"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.01.009","relation":{},"ISSN":["0003-4509"],"issn-type":[{"type":"print","value":"0003-4509"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Green approach for simultaneous determination of long-acting \u03b2-agonists, their organic counterparts and corticosteroids by HPLC coupled with PDA detector","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}